James Bruno, MD
Plastic Surgery · Chevy Chase, MDNPI 1861439887
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,464 of the $4,654 with a category attached, or 74.4%. AbbVie accounts for 64.5% of it on its own, with 14 other manufacturers making up the rest.
Across 86 payments — averaging $54.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Mentor Worldwide LLC$465
- Revance Therapeutics, Inc.$259
- TELA Bio, Inc.$258
- Motiva USA, LLC$203
- Baxter Healthcare$119
- plus $346 from 9 others
Across 1 payment — averaging $14,882 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$15K
What the payments were for
- Consulting fees$59513%
- Speaking & faculty fees$59513%
- Food & beverage$3,46474%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 50 | $3,003 |
| Mentor Worldwide LLC | 7 | $465 |
| Revance Therapeutics, Inc. | 3 | $259 |
| TELA Bio, Inc. | 5 | $258 |
| Motiva USA, LLC | 5 | $203 |
| Baxter Healthcare | 3 | $119 |
| Integra Lifesciences Corporation | 3 | $92 |
| Axogen | 2 | $74 |
| Sientra, Inc. | 2 | $50 |
| Innovation Technologies Inc | 1 | $32 |
| Johnson & Johnson | 1 | $28 |
| Coopersurgical, Inc. | 1 | $21 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Novo Nordisk | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,654 in reported general payments places this provider in the 65th percentile of 105 plastic surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 38 | $1,799 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 37 | $160 |
| Diazepam | 36 | $73 |
| Ondansetron Hcl | 38 | $61 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Chevy Chase
- Samir RaoChevy Chase$26K
- Frank AlbinoChevy Chase$25K
- Navin SinghChevy Chase$16K
- Ornela KutzkeChevy Chase$5K
- Christopher BrownChevy Chase$4K
- Sheilah LynchChevy Chase$2K
- Wendell MilesChevy Chase$2K
- Chad GordonBaltimore$2.9M
- Larry LicksteinTowson$271K
- Sarah MessColumbia$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.